U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07005466) titled 'Bronchoalveolar Lavage Combined With High-throughput Sequencing Technology' on May 26.
Brief Summary: High-throughput sequencing technology/Metagenomic next generation sequencing (mNGS) has extensive applications in fields such as whole-genome sequencing, transcriptome, gene expression regulation, and epigenetics. Because mNGS has the characteristics of large sequencing throughput, short time and high sensitivity, it can detect thousands of pathogens including bacteria, viruses, true bacteria and parasites, and is widely used in infectious diseases. In 2020, the "Expert Consensus on the Clinical Application of Metagenomic Second-Gene...